31 completed. 31 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 31 | Completed 31 |
| Phase 2 | 1 | Completed 1 |
Follow Neuroblastoma: new trials by email Literature Review of Neuroblastoma trials Research Report on Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study of 18F-mFBG for Imaging Neuroblastoma 18F-MFBG - Neuroblastoma | Phase 3 | Completed | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 43 | 2021-11-18 | 2026-09-29 |
| 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety 18F-DOPA - Congenital Hyperinsulinism, Neuroblastoma | Phase 3 | Completed | University of Alberta | 400 | 2017-06-29 | 2022-01-10 |
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Dexamethasone acetate, dexamethasone and cyclophosphamide, dexamethasone and rituximab - Opsoclonus Myoclonus Syndrome, Neuroblastoma | Phase 3 | Completed | Institut Curie | 102 | 2013-04-18 | 2025-02-03 |
| European Low and Intermediate Risk Neuroblastoma Protocol chemotherapy - LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES | Phase 3 | Completed | Instituto de Investigacion Sanitaria La Fe | 685 | 2011-01-01 | 2023-09-08 |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy doxepin hydrochloride, placebo - Head and Neck Cancer, Mucositis | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 155 | 2010-12-01 | 2017-08-09 |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy sodium thiosulfate, examination - Brain Tumor, Central Nervous System Tumor | Phase 3 | Completed | Children's Oncology Group | 131 | 2008-06-23 | 2023-11-09 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families educational intervention, informational intervention, internet-based intervention - Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Completed | Tufts Medical Center | 198 | 2008-06-01 | 2011-07-13 |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cisplatin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 665 | 2007-11-05 | 2022-04-28 |
| Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma carboplatin, cyclophosphamide, doxorubicin hydrochloride - Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 464 | 2007-10-08 | 2021-07-06 |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients Cycles N8, N5 and N6, Cycles N5 and N6 - Neuroblastoma | Phase 3 | Completed | University of Cologne | 360 | 2007-01-01 | 2017-02-06 |
| Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma 123I-mIBG (meta-iodobenzylguanidine) - Pheochromocytoma, Neuroblastoma | Phase 3 | Completed | GE Healthcare | 251 | 2005-08-02 | 2019-05-31 |
| GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer sargramostim, oral salt and soda mouthwash - Head and Neck Cancer, Mucositis Oral | Phase 3 | Completed | Marilyn Dodd | 91 | 2005-06-07 | 2021-07-30 |
| Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 53 | 2004-03-15 | 2023-04-18 |
| Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer acupuncture therapy, standard follow-up care - Head and Neck Cancer, Pain | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 73 | 2003-11-01 | 2013-03-07 |
| Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation acyclovir, acyclovir sodium, valacyclovir - Cancer | Phase 3 | Completed | Fred Hutchinson Cancer Center | 2002-04-01 | 2010-09-21 | |
| Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Aldesleukin, Dinutuximab, Isotretinoin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1449 | 2001-10-26 | 2026-03-05 |
| Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer cevimeline hydrochloride - Head and Neck Cancer, Oral Complications | Phase 3 | Completed | Daiichi Sankyo | 2001-06-01 | 2012-05-16 | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma filgrastim, carboplatin, cisplatin - Neuroblastoma | Phase 3 | Completed | Children's Oncology Group | 495 | 2001-02-01 | 2013-05-17 |
| Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma carboplatin, cyclophosphamide, doxorubicin hydrochloride - Neuroblastoma | Phase 3 | Completed | Societe Internationale d'Oncologie Pediatrique | 100 | 2000-12-01 | 2013-12-04 |
Showing 20 of 31. Sign in to see all of them.
Blast Crisis (8) · Burkitt Lymphoma (8) · Leukemia, Myeloid, Accelerated Phase (8) · Leukemia, Myeloid, Chronic-Phase (8) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (8) · Primary Myelofibrosis (8) · Testicular Neoplasms (8) · Breast Neoplasms (7) · Carcinoma, Ovarian Epithelial (7) · Esthesioneuroblastoma, Olfactory (7) · Hodgkin Disease (7) · Leukemia, Hairy Cell (7) · Leukemia, Lymphocytic, Chronic, B-Cell (7) · Leukemia, Myeloid, Acute (7)
Neoplasms by Histologic Type (31) · Neoplasms, Germ Cell and Embryonal (31) · Neoplasms, Glandular and Epithelial (31) · Neoplasms, Nerve Tissue (31) · Neoplasms, Neuroepithelial (31) · Neuroectodermal Tumors (31) · Neuroectodermal Tumors, Primitive (30) · Neuroectodermal Tumors, Primitive, Peripheral (30) · Neoplasms (24) · Neoplasms by Site (16) · Pathological Conditions, Signs and Symptoms (13) · Carcinoma (12) · Nervous System Diseases (10) · Pathologic Processes (10) · Adnexal Diseases (9)
Cyclophosphamide (12) · Etoposide (9) · Carboplatin (8) · Doxorubicin (8) · Cisplatin (5) · Filgrastim (5) · Vincristine (5) · Granulocyte Colony-Stimulating Factor (4) · Isotretinoin (4) · Melphalan (4) · Radiotherapy (4) · Topotecan (4) · sargramostim (4) · Peripheral Blood Stem Cell Transplantation (3) · Chemotherapy, Adjuvant (2)
Children's Oncology Group (7) · Fred Hutchinson Cancer Center (3) · Memorial Sloan Kettering Cancer Center (2) · Alliance for Clinical Trials in Oncology (1) · Children's Cancer and Leukaemia Group (1) · Children's Hospital Medical Center, Cincinnati (1) · Daiichi Sankyo (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · GE Healthcare (1) · INSYS Therapeutics Inc (1) · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) (1) · Institut Curie (1) · Instituto de Investigacion Sanitaria La Fe (1) · Marilyn Dodd (1) · National Cancer Institute (NCI) (1)
United States (23) · Canada (9) · Australia (8) · Switzerland (6) · New Zealand (5) · Puerto Rico (5) · Germany (4) · Italy (4) · Netherlands (4) · Spain (4) · Sweden (4) · Austria (3) · Belgium (3) · France (3) · Denmark (2)
Alice L Yu (1) · Andrea di Cataldo (1) · Andrew David J. Pearson, MD, FRCP, DCh (1) · Arnold F Jacobson, MD, PhD (1) · Arnold M. Markoe, MD, ScD (1) · Charles Ross Pinkerton, MD (1) · Clare Twist, MD (1) · David G. Pfister, MD (1) · David L. Baker, MD, MBBS, FRACP, FRCPA (1) · David R. Freyer, DO, MS (1) · Diane McCaul (1) · Douglas R. Strother, MD (1) · Frank Berthold, MD (1) · Frank Berthold, Prof. (1)
PMID 10882162, PMID 11464889, PMID 12101494, PMID 12165894, PMID 12880954, PMID 12932669, PMID 15459300, PMID 16129365, PMID 18308250, PMID 20406930, PMID 20879880, PMID 20879881, PMID 21328522, PMID 22480131, PMID 22529259, PMID 23281263, PMID 23890779, PMID 24419114, PMID 24733799, PMID 27020837, PMID 27914822, PMID 29376112, PMID 30444686, PMID 31386611, PMID 31454045, PMID 32530765, PMID 35839426, PMID 37883734, PMID 40036726, PMID 41073929
U10CA098543 (3), U10CA180886 (3), P30CA008748 (1), R01CA107080 (1), R01CA119196 (1), R21CA098792 (1), U10CA013539 (1), U10CA030969 (1), U10CA037404 (1)